Human Papillomavirus (HPV): Clinical Trials

17 trials for Human Papillomavirus (HPV), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 not yet recruiting, 3 recruiting, 1 enrolling by invitation. 8 Not applicable, 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 3, Recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Unknown 1
Phase 24Completed 1, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 11Completed 1

Follow Human Papillomavirus (HPV): new trials by email Literature Review of Human Papillomavirus (HPV) trials Research Report on Human Papillomavirus (HPV)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
C2001P-CS3: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
HPV DNA Testing (Abbott Alinity m HPV Assay), Visual Inspection with Acetic Acid, Cervical Histology (Biopsy Procedures) - Human Papillomavirus (HPV), HPV Associated Cancers
Not applicableNot yet recruitingUniversity of California, San Diego7502026-11-302026-10-29
C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States
Qualitative interviews, Focus groups - Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV)
Not yet recruitingUNC Lineberger Comprehensive Cancer Center35002026-11-102026-10-20
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
PRGN-2012, Bevacizumab - Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
Phase 2Not yet recruitingNational Cancer Institute (NCI)502026-11-042026-10-30
The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions
TTM-Based Educational Program - Human Papillomavirus (HPV), Papillomavirus Vaccines
Not applicableRecruitingCukurova University882026-01-162026-03-27
Effect of HPV Education on Women's Knowledge
HPV Awareness Education Group - Human Papillomavirus (HPV), Awareness and Knowledge Level
Not applicableCompletedKahramanmaras Sutcu Imam University1102025-10-022026-07-08
Primary HPV Self-Collection in Indonesia
HPV Self-Collection - Cervical Cancers, CIN - Cervical Intraepithelial Neoplasia
Not applicableEnrolling by invitationDharmais National Cancer Center Hospital80002025-08-132025-09-17
Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer
HPV Test, EVA System, Visual Inspection with Acetic Acid (VIA) - Human Papillomavirus (HPV), Cervical Intraepithelial Neoplasia
Not applicableRecruitingDL Analytics100002025-02-122026-01-29
Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections
Participatory teaching group, Sham control group - Chlamydia Infections, Gonorrhea
Not applicableUnknownFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina12002023-03-012023-02-14
The Role of Circulating Tumour DNA in Head and Neck Cancer
Oropharyngeal Squamous Cell Carcinoma, Human Papillomavirus (HPV)
RecruitingUniversity of Edinburgh2502022-08-142026-03-17
RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC
RT 50 Gy, RT 54 GY, RT 60 GY - Human Papillomavirus (HPV), Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2WithdrawnIcahn School of Medicine at Mount Sinai2022-06-142022-07-07
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
VGX-3100, Imiquimod 5% Cream, CELLECTRA™ 2000 - Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia
Phase 2CompletedInovio Pharmaceuticals332017-08-312023-08-25
New Strategies to Assess Anal Cancer Risk In Women
Perianal and Digital Anorectal Exam, Cervical Swabs, Anal Swabs - Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV)
CompletedEmory University1432016-07-012019-11-06
AMG 319 in HPV Positive and Negative HNSCC
AMG 319 hydrate, Placebo - Human Papillomavirus (HPV), Positive or Negative Head and Neck Squamous Cell Carcinoma (HNSCC) of the Hypopharynx, Oropharynx, Oral Cavity, Supraglottis or Larynx
Phase 2TerminatedCancer Research UK352015-10-012018-07-18
Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics
Provider assessment and feedback, Provider reminders, Provider education - Human Papillomavirus (HPV)
Not applicableCompletedThe University of Texas Health Science Center, Houston10002015-03-012020-05-21
Prevalence of HPV Transmission During Medically Assisted Procreation Procedures
Systematic HPV DNA assay in semen and cervicovaginal scrape, Systematic HPV DNA cervicovaginal scrape, systematic HPV Status in newborns in case of pregnancy - Human Papillomavirus (HPV), Medically Assisted Procreation (MAP)
Not applicableCompletedCentre Hospitalier Universitaire de Saint Etienne9152012-07-122018-09-24
Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years
Survey - Human Papillomavirus (HPV)
CompletedAnn & Robert H Lurie Children's Hospital of Chicago5002010-08-012025-03-28
Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100
VGX-3100 - Human Papillomavirus (HPV)
Phase 1CompletedInovio Pharmaceuticals142010-07-012018-08-10

Narrower conditions

Uterine Cervical Neoplasms (5)  ·  Acquired Immunodeficiency Syndrome (4)  ·  Uterine Cervical Dysplasia (4)  ·  Squamous Cell Carcinoma of Head and Neck (3)  ·  Laryngeal Diseases (2)  ·  Neoplasms (2)  ·  Sexually Transmitted Diseases (2)  ·  Behavior (1)  ·  Chlamydia Infections (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Gonorrhea (1)  ·  Health Behavior (1)

Broader conditions

Genital Diseases (8)  ·  Neoplasms (8)  ·  Neoplasms by Site (8)  ·  Urogenital Diseases (8)  ·  Communicable Diseases (5)  ·  Female Urogenital Diseases (5)  ·  Infections (5)  ·  Sexually Transmitted Diseases, Viral (5)  ·  Virus Diseases (5)  ·  Blood-Borne Infections (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases, Female (4)  ·  Genital Neoplasms, Female (4)  ·  HIV Infections (4)  ·  Immune System Diseases (4)

Interventions

Acetic Acid (2)  ·  Transurethral Resection of Prostate (2)  ·  VGX-3100 (2)  ·  Watchful Waiting (2)  ·  Bevacizumab (1)  ·  Biopsy (1)  ·  Carboplatin (1)  ·  Colposcopy (1)  ·  Focus Groups (1)  ·  Health (1)  ·  Human Papillomavirus DNA Tests (1)  ·  Imiquimod (1)  ·  Neoadjuvant Therapy (1)  ·  Pregnancy Tests (1)  ·  Radiotherapy (1)

Sponsors

Inovio Pharmaceuticals (2)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Cancer Research UK (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Cukurova University (1)  ·  DL Analytics (1)  ·  Dharmais National Cancer Center Hospital (1)  ·  Emory University (1)  ·  Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Kahramanmaras Sutcu Imam University (1)  ·  National Cancer Institute (NCI) (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  University of California, San Diego (1)

Countries

United States (8)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Botswana (1)  ·  El Salvador (1)  ·  France (1)  ·  Indonesia (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

Anandi Sheth, MD, MSc (1)  ·  Ashley Tay (1)  ·  Catriona Douglas (1)  ·  Clement S Adebamowo, ScD (1)  ·  David Levitz, PhD (1)  ·  Dian T Sinulingga, MD, M.Epid (1)  ·  Gregory Taylor, MD (1)  ·  Jaiganesh Manickavasagam (1)  ·  Javier Morales, MD (1)  ·  Jeffrey Skolnik, MD (1)  ·  Jennifer S Smith, PhD (1)  ·  John Sunyecz, MD (1)  ·  Karla Alfaro, MD (1)  ·  Katie Mollan, PhD (1)

NIH funding

U24CA275417 (2), R44CA247137 (1), U01AI103408 (1), UG1CA275403 (1), UG1CA275414 (1), UG1CA275416 (1), UG1CA284883 (1), UG1CA284884 (1)